Related references
Note: Only part of the references are listed.Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
Steven M. Rowe et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Antibacterial properties of the CFTR potentiator ivacaftor
Leah R. Reznikov et al.
JOURNAL OF CYSTIC FIBROSIS (2014)
The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation
Verena I. Seliger et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung
Alejandro A. Pezzulo et al.
NATURE (2012)
Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis
Nicole Mayer-Hamblett et al.
PEDIATRIC PULMONOLOGY (2012)
Clearance of initial mucoid Pseudomonas aeruginosa in patients with cystic fibrosis
Robert Bradley Troxler et al.
PEDIATRIC PULMONOLOGY (2012)
Comparative Efficacy and Safety of 4 Randomized Regimens to Treat Early Pseudomonas aeruginosa Infection in Children With Cystic Fibrosis
Miriam M. Treggiari et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2011)
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Bonnie W. Ramsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Changing Microbial Epidemiology in Cystic Fibrosis
John J. LiPuma
CLINICAL MICROBIOLOGY REVIEWS (2010)
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation
Frank J. Accurso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005
Samiya Razvi et al.
CHEST (2009)
Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis
T. A. Douglas et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis - a review
Marc Pihet et al.
MEDICAL MYCOLOGY (2009)
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience
C. R. Hansen et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Cystic fibrosis pulmonary guidelines - Chronic medications for maintenance of lung health
Patrick A. Flume et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients
Thomas S. Murray et al.
CURRENT OPINION IN PEDIATRICS (2007)
Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis
Richard Kraemer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
CFTR regulates phagosome acidification in macrophages and alters bactericidal activity
Anke Di et al.
NATURE CELL BIOLOGY (2006)
Pseudomonas aeruginosa pyocyanin inactivates lung epithelial vacuolar ATPase-dependent cystic fibrosis transmembrane conductance regulator expression and localization
Fansheng Kong et al.
CELLULAR MICROBIOLOGY (2006)
Mechanisms of disease: Cystic fibrosis
SM Rowe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis
ZH Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center
TWR Lee et al.
PEDIATRIC PULMONOLOGY (2004)
Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient-transmission
L Saiman et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis
RL Gibson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Early infection and progression of cystic fibrosis lung disease
C Koch
PEDIATRIC PULMONOLOGY (2002)
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis
J Emerson et al.
PEDIATRIC PULMONOLOGY (2002)
Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis -: Early detection by serology and assessment of risk factors
SEH West et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-κB translocation
TH Schroeder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Bias and causal associations in observational research
DA Grimes et al.
LANCET (2002)
Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition
MR Kosorok et al.
PEDIATRIC PULMONOLOGY (2001)
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis
JL Burns et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections
GB Pier
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
